Gene: TTC4
Official Full Name: tetratricopeptide repeat domain 4provided by HGNC
Gene Summary: This gene encodes a protein that contains tetratricopeptide (TPR) repeats, which often mediate protein-protein interactions and chaperone activity. The encoded protein interacts with heat shock proteins 70 and 90. Alternative splicing results in multiple transcript variants. Naturally-occuring readthrough transcription occurs from upstream gene MROH (maestro heat-like repeat family member 7) to this gene. [provided by RefSeq, Apr 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34913 | TTC4 Knockout cell line (HeLa) | Human | TTC4 | 1:3~1:6 | Negative | Online Inquiry |
KO34914 | TTC4 Knockout cell line (HCT 116) | Human | TTC4 | 1:2~1:4 | Negative | Online Inquiry |
KO34915 | TTC4 Knockout cell line (HEK293) | Human | TTC4 | 1:3~1:6 | Negative | Online Inquiry |
TTC4 Gene Knockout Cell Lines are specialized cellular models developed through precise genetic engineering techniques to disable the TTC4 gene, which encodes for a protein involved in several cellular processes such as growth, differentiation, and stress response. By systematically knocking out the TTC4 gene, these cell lines provide an invaluable tool for investigating the functional implications of TTC4 in various biological contexts.
The mechanism underlying these cell lines involves the targeted disruption of the TTC4 gene using advanced CRISPR-Cas9 technology, allowing researchers to create specific gene knockouts with high efficiency and accuracy. By eliminating the expression of the TTC4 protein, scientists can study downstream signaling pathways and cellular responses, offering pivotal insights into its role in disease mechanisms, particularly in cancer biology and metabolic disorders.
The scientific significance of TTC4 Gene Knockout Cell Lines lies in their application across both research and clinical settings, enabling studies that can lead to the development of novel therapeutic strategies. These models serve as platforms for drug screening and functional genomics, thus facilitating the identification of potential pharmacological targets and biomarkers for disease progression.
What sets TTC4 Gene Knockout Cell Lines apart from alternative products is their optimized performance in various assays, including proliferation, apoptosis, and migration studies. Furthermore, these cell lines come with comprehensive validation data, ensuring reliability and reproducibility in research findings. The ease of use and implementation into existing experimental frameworks promote their integration in diverse study designs, making them a favorite among researchers and clinicians.
In summary, TTC4 Gene Knockout Cell Lines represent a significant advancement in the field of molecular biology, providing researchers with the means to dissect the complexities of gene function, contributing to a richer understanding of pathophysiology. Our company prides itself on its commitment to quality and innovation, offering a range of cutting-edge biological products designed to enhance research capabilities and support scientific discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.